Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.

By A. Lesokhin, S. Ansell, P. Armand, E. Scott, A. Halwani, M. Gutierrez, M. Millenson, A. Cohen, S. Schuster, D. Lebovic and 13 more. Journal of Clinical Oncology, 2016

938 citations recorded by the source corpus.

Subfields: Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/1023edbee5f4896fdd1e1de0e8c6cb2f74226096